Literature DB >> 16172378

HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation.

Carla Oseroff1, Ferdynand Kos, Huynh-Hoa Bui, Bjoern Peters, Valerie Pasquetto, Jean Glenn, Tara Palmore, John Sidney, David C Tscharke, Jack R Bennink, Scott Southwood, Howard M Grey, Jonathan W Yewdell, Alessandro Sette.   

Abstract

We have analyzed by ex vivo ELISPOT the anti-vaccinia cytotoxic T lymphocyte responses of peripheral blood mononuclear cells from humans vaccinated with Dryvax vaccine. More than 6,000 peptides from 258 putative vaccinia ORFs predicted to bind the common molecules of the HLA A1, A2, A3, A24, B7, and B44 supertypes were screened with peripheral blood mononuclear cells of 31 vaccinees. A total of 48 epitopes derived from 35 different vaccinia antigens were identified, some of which (B8R, D1R, D5R, C10L, C19L, C7L, F12, and O1L) were recognized by multiple donors and contain multiple epitopes recognized in the context of different HLA types. The antigens recognized tend to be >100 residues in length and are expressed predominantly in the early phases of infection, although some late antigens were also recognized. Viral genome regulation and virulence factor were recognized most frequently, whereas few structural proteins were immunogenic. Finally, most epitopes were highly conserved among vaccinia virus Western Reserve, variola major and modified vaccinia Ankara, supporting their potential use in vaccine and diagnostic applications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16172378      PMCID: PMC1236582          DOI: 10.1073/pnas.0506768102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules.

Authors:  J Sidney; S Southwood; D L Mann; M A Fernandez-Vina; M J Newman; A Sette
Journal:  Hum Immunol       Date:  2001-11       Impact factor: 2.850

3.  Transmission potential of smallpox in contemporary populations.

Authors:  R Gani; S Leach
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

4.  Shining light on "Dark Winter".

Authors:  Tara O'Toole; Michael Mair; Thomas V Inglesby
Journal:  Clin Infect Dis       Date:  2002-02-19       Impact factor: 9.079

5.  Using a baculovirus display library to identify MHC class I mimotopes.

Authors:  Yibing Wang; Anatoyla Rubtsov; Ryan Heiser; Janice White; Frances Crawford; Philippa Marrack; John W Kappler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

6.  A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays.

Authors:  Jeffrey R Currier; Ellen G Kuta; Ellen Turk; Lyndsay B Earhart; Larry Loomis-Price; Sylvia Janetzki; Guido Ferrari; Deborah L Birx; Josephine H Cox
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

Review 7.  Immune response to poxvirus infections in various animals.

Authors:  Scott A Smith; Girish J Kotwal
Journal:  Crit Rev Microbiol       Date:  2002       Impact factor: 7.624

8.  Modeling potential responses to smallpox as a bioterrorist weapon.

Authors:  M I Meltzer; I Damon; J W LeDuc; J D Millar
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

9.  Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.

Authors:  Ingo Drexler; Caroline Staib; Wolfgang Kastenmuller; Stefan Stevanović; Burkhard Schmidt; François A Lemonnier; Hans-Georg Rammensee; Dirk H Busch; Helga Bernhard; Volker Erfle; Gerd Sutter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

10.  Structural features of peptide analogs of human histocompatibility leukocyte antigen class I epitopes that are more potent and immunogenic than wild-type peptide.

Authors:  S Tangri; G Y Ishioka; X Huang; J Sidney; S Southwood; J Fikes; A Sette
Journal:  J Exp Med       Date:  2001-09-17       Impact factor: 14.307

View more
  77 in total

Review 1.  Discovering protective CD8 T cell epitopes--no single immunologic property predicts it!

Authors:  Pavlo Gilchuk; Timothy M Hill; John T Wilson; Sebastian Joyce
Journal:  Curr Opin Immunol       Date:  2015-02-06       Impact factor: 7.486

Review 2.  Initiation of primary anti-vaccinia virus immunity in vivo.

Authors:  Matthew A Fischer; Christopher C Norbury
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

3.  Vaccinia virus-specific CD8(+) T-cell responses target a group of epitopes without a strong immunodominance hierarchy in humans.

Authors:  Masanori Terajima; Laura Orphin; Anita M Leporati; Pamela Pazoles; John Cruz; Alan L Rothman; Francis A Ennis
Journal:  Hum Immunol       Date:  2008-10-26       Impact factor: 2.850

Review 4.  The two faces of heterologous immunity: protection or immunopathology.

Authors:  Shalini Sharma; Paul G Thomas
Journal:  J Leukoc Biol       Date:  2013-11-08       Impact factor: 4.962

5.  Dissociation between epitope hierarchy and immunoprevalence in CD8 responses to vaccinia virus western reserve.

Authors:  Carla Oseroff; Bjoern Peters; Valerie Pasquetto; Magdalini Moutaftsi; John Sidney; Vijay Panchanathan; David C Tscharke; Bernard Maillere; Howard Grey; Alessandro Sette
Journal:  J Immunol       Date:  2008-06-01       Impact factor: 5.422

Review 6.  Immunogenetics of seasonal influenza vaccine response.

Authors:  Gregory A Poland; Inna G Ovsyannikova; Robert M Jacobson
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

Review 7.  Definition of epitopes and antigens recognized by vaccinia specific immune responses: their conservation in variola virus sequences, and use as a model system to study complex pathogens.

Authors:  Alessandro Sette; Howard Grey; Carla Oseroff; Bjoern Peters; Magdalini Moutaftsi; Shane Crotty; Erika Assarsson; Jay Greenbaum; Yohan Kim; Ravi Kolla; David Tscharke; David Koelle; R Paul Johnson; Janice Blum; Steven Head; John Sidney
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

8.  IMMUNOCAT-a data management system for epitope mapping studies.

Authors:  Jo L Chung; Jian Sun; John Sidney; Alessandro Sette; Bjoern Peters
Journal:  J Biomed Biotechnol       Date:  2010-05-17

9.  Concept and application of a computational vaccinology workflow.

Authors:  Johannes Söllner; Andreas Heinzel; Georg Summer; Raul Fechete; Laszlo Stipkovits; Susan Szathmary; Bernd Mayer
Journal:  Immunome Res       Date:  2010-11-03

10.  Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?

Authors:  Maya F Kotturi; Erika Assarsson; Bjoern Peters; Howard Grey; Carla Oseroff; Valerie Pasquetto; Alessandro Sette
Journal:  Immunome Res       Date:  2009-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.